Infection and Immunity, May 2000, p. 2546-2552, Vol. 68, No. 5
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas, Medellín, Colombia
Received 16 August 1999/Returned for modification 22 September 1999/Accepted 26 January 2000
| |
ABSTRACT |
|---|
|
|
|---|
Paracoccidioidomycosis, a systemic mycosis restricted to Latin
America and produced by the dimorphic fungus Paracoccidioides brasiliensis, is probably acquired by inhalation of conidia
produced by the mycelial form. The macrophage (M
) represents the
major cell defense against this pathogen; when activated with gamma interferon (IFN-
), murine M
s kill the fungus by an
oxygen-independent mechanism. Our goal was to determine the role of
nitric oxide in the fungicidal effect of M
s on P. brasiliensis conidia. The results revealed that IFN-
-activated
murine M
s inhibited the conidium-to-yeast transformation process in
a dose-dependent manner; maximal inhibition was observed in M
s
activated with 50 U/ml and incubated for 96 h at 37°C. When
M
s were activated with 150 to 200 U of cytokine per ml, the number
of CFU was 70% lower than in nonactivated controls, indicating that
there was a fungicidal effect. The inhibitory effect was reversed by
the addition of anti-IFN-
monoclonal antibodies. Activation by
IFN-
also enhanced M
nitric oxide production, as revealed by
increasing NO2 values (8 ± 3 µM in nonactivated
M
s versus 43 ± 13 µM in activated M
s). The neutralization
of IFN-
also reversed nitric oxide production at basal levels
(8 ± 5 µM). Additionally, we found that there was a significant
inverse correlation (r =
0.8975) between
NO2
concentration and transformation of
P. brasiliensis conidia. Additionally, treatment with any
of the three different nitric oxide inhibitors used (arginase,
NG-monomethyl-L-arginine, and
aminoguanidine), reverted the inhibition of the transformation process
with 40 to 70% of intracellular yeast and significantly reduced nitric
oxide production. These results show that IFN-
-activated murine
M
s kill P. brasiliensis conidia through the
L-arginine-nitric oxide pathway.
| |
INTRODUCTION |
|---|
|
|
|---|
The mononuclear phagocytic system
constitutes an important effector mechanism in the natural and
adaptative immune responses against several pathogens. Kashino et al.
(25) suggested that macrophages (M
s) play a fundamental
role in resistance to the dimorphic fungus Paracoccidioides
brasiliensis, the etiological agent of paracoccidioidomycosis
(PCM), one of most common systemic mycoses in Latin America (17,
39).
Previous studies have demonstrated that murine peritoneal M
s
activated with the cytokine gamma interferon (IFN-
) exert a fungicidal effect on both yeast and conidial forms of P. brasiliensis (5, 8, 9). These findings also suggested
that cytokines, especially IFN-
, play an important protective role
in resistance to PCM, as demonstrated recently by Cano et al.
(10) using IFN-
depletion in intratracheally infected
A/Sn and B/10.A mice. This depletion caused an exacerbation of
pulmonary infection and earlier dissemination to the liver and spleen
of both resistant (A/Sn) and susceptible (B/10.A) animals.
Additionally, it was shown that killing was independent of the
oxidative burst products (5).
M
s activated by IFN-
, tumor necrosis factor alpha (TNF-
), or
lipopolysaccharide (LPS) produce two kind of reactive products characterized by their cytotoxic activity: reactive oxygen
intermediates and reactive nitrogen intermediates (RNI) (16,
36).
Nitric oxide (NO), one of the most important RNI, is generated by the
oxidation of one of the nitrogens in the amino acid L-arginine (21, 22). The inducible nitric oxide
synthase (iNOS) is responsible for NO production and is involved in
inflammation and infection (30). There is no evidence that
in M
s iNOS can be expressed without previous intervention of
cytokines (such as IFN-
) and microbial products, such as LPS.
More direct evidence for the role of iNOS has been afforded by
the identification of relatively selective, nontoxic compounds that
inhibit this enzyme. Aminoguanidine a nucleophilic hydrazine compound whose methylation results in the loss of both potency and
selectivity for iNOS (14), has been identified as an
iNOS-selective inhibitor.
NG-monomethyl-L-arginine acetate
salt (LNMMA), another NO inhibitor, has been shown to antagonize the
L-arginine-dependent cytotoxicity on activated M
s
(20). Additionally, arginase (ARG) acts directly on the
specific substrate, L-arginine, blocking the reaction.
Experimental models have demonstrated that NO is responsible for
the cytotoxic effect exerted on a variety of microorganisms, including certain parasites, such as Schistosoma mansoni
(23), Leishmania major amastigotes (4, 19,
29, 31), Trypanosoma cruzi (34,
37), and Plasmodium falciparum and P. chaubaudii (12, 42) and several fungi, such as
Cryptococcus neoformans (18), Histoplasma
capsulatum (27, 35), the hyphal form of Candida
albicans (1), and the yeast form of Penicillium
marneffei (26). However, NO does not appear to be
involved in the fungicidal activity of murine or human alveolar
M
s against other fungi such as Aspergillus
fumigatus conidia (32, 41) and Pneumocystis carinii (40).
The purpose of this work was to determine if the cytotoxic effect
exerted by recombinant IFN-
(rIFN-
)-activated murine peritoneal M
s against intracellular P. brasiliensis conidia is
mediated by an NO production mechanism. Additionally, we attempted to
determine if NO produced by these activated M
s was directly
responsible for the cytotoxic effects observed previously (8,
9).
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Male BALB/c mice, 8 to 12 weeks old, obtained from the breeding colony of the Corporación para Investigaciones Biológicas, Medellín, Colombia, were used in all experiments. Mice were supplied with sterilized commercial food pellets, sterilized bedding, and fresh acidified water.
Reagents and media.
Tissue culture medium RPMI 1640, fetal
bovine serum, sulfanilamide, naphthylethylenediamine
dihydrochloride, phosphoric acid (H3PO4),
aminoguanidine hemisulfate salt (AG), LNMMA, and ARG were
purchased from Sigma Chemical Co., St. Louis, Mo. Complete tissue
culture medium (CTCM) consisted of RPMI 1640 containing 10% (vol/vol)
heat-inactivated fetal bovine serum, 100 U of penicillin, and 100 µg
of streptomycin per ml. Mouse rIFN-
and anti-IFN-
monoclonal
antibody (MAb) (purified anti-mouse IFN-
) were obtained from
PharMingen, San Diego, Calif.
Fungus and production of conidia. P. brasiliensis isolate ATCC 60855, previously found to sporulate freely on special media, was used (38). The techniques used to grow the mycelial form and collect and dislodge conidia have been reported previously (38). Briefly, the stock mycelial culture was grown in a liquid synthetic medium, modified McVeigh-Morton broth, at 18 ± 4°C with shaking. Growth was homogenized, and portions were used to inoculate agar plates; the latter were incubated at 18 ± 4°C for 2 months. After this time, sterile physiological saline containing 0.01% Tween 20, 100 U of penicillin, and 100 µg of streptomycin per ml was used to flood the culture surface. Growth was removed with a bacteriological loop; the resulting suspension was pipetted into an Erlenmeyer flask containing glass beads and then shaken in a reciprocating shaker at 250 rpm for 30 min. The homogeneous suspension was filtered through a syringe packed with sterile glass wool (Pyrex fiber glass, 8-µm pore size; Corning Glass Works, Corning, N.Y.). The filtrate was collected in a polycarbonate centrifuge tube and centrifuged for 30 min at 1,300 × g; the pelleted conidia were washed and counted with a hemacytometer, and their viability was assessed by the ethidium bromide-fluorescein diacetate technique (6). For the experiments, only inocula with a conidial viability of >90% were used.
Peritoneal M
s.
Peritoneal cells (PC) were collected from
the abdominal cavity of each of 10 to 12 BALB/c mice by repeated lavage
with 10 ml of fresh RPMI 1640 plus 100 U of penicillin and 100 µg of
streptomycin. PC from all mice were pelleted by centrifugation at
200 × g for 10 min and then pooled. PC were washed
once and resuspended at 106 cell per ml of CTCM. A 0.25-ml
volume of PC was dispensed into each chamber of the eight-chambered
Lab-Tek slides (Nunc, Inc., Naperville, Ill.). Cultures were incubated
at 37°C in 5% CO2-95% air for 2 h; then the
nonadherent cells were removed by aspiration, and the adherent
monolayers were rinsed with RPMI 1640. The number of nonadherent cells
was determined and subtracted from the number of incubated PC.
Approximately 2 × 105 adherent cells per chamber
formed a monolayer (8, 9).
Treatment of M
monolayers.
M
monolayers were kept
overnight at 37°C in 5% CO2-95% air and treated with
0.25 ml of CTCM or CTCM containing different concentrations of rIFN-
(10 to 200 U/ml). When anti-IFN-
MAb and NO inhibitors were used,
they were diluted in CTCM and then added to the monolayer at different
concentrations (41.7 to 333.3 ng/ml for MAb; 1.0 to 10 U/ml for ARG;
and 0.05 to 1.0 mM for LNMMA and AG).
Infection of M
s.
Conidia were suspended in 2 ml of CTCM
containing 30% (vol/vol) fresh mouse serum from the same normal BALB/c
mice used to obtain M
s. Conidial suspensions were incubated at
37°C for 20 min for opsonization to take place (7). M
monolayers were infected with 0.02 ml of the conidial suspension, which
gave a conidium-to-M
ratio of 1:10 (8, 9).
Time course measurements.
The above cocultures were
incubated at 37°C in 5% CO2-95% air for 24, 48, 72, and 96 h. After each incubation period, duplicate sets of culture
supernatants were withdrawn and stored at
70°C for NO
determination. The slides were fixed with absolute methanol, air dried,
and stained by the silver methenamine (Gomori) or modified Wright
(Sigma) technique.
Microscopic determination of intracellular transformation.
Over 200 intracellular P. brasiliensis fungal cells were
examined per monolayer, and the morphology of the fungus, e.g.,
conidium, yeast cells, or multiple budding yeasts, was recorded (Fig.
1). Percent transformation was calculated
as number of intracellular yeast cells/200 intracellular fungal
cells × 100.
|
CFU determination.
After incubation of cocultures at 37°C
in 5% CO2-95% air for 6, 7, and 8 days, cells were
harvested by aspiration and washed with distilled water to lyse M
s.
Each coculture supernatant and the corresponding washings were mixed to
a final volume of 1 ml. The total volume of each well was plated on
Sabouraud dextrose agar, modified (Mycosel; BBL). Plates were incubated
at 18°C, and colonies were counted daily until no increase in CFU was
observed. Percent fungicidal activity was calculated as 100
(experimental CFU × 100)/control [M
without rIFN-
] CFU).
NO determination. The concentration of NO2 in the culture supernatant was used as an indicator of NO generation and measured with the Griess reagent (1% sulfanilamide, 0.1% naphthylethylenediamine dihydrochloride, 2.5% H3PO4) (15). Briefly, 50 µl of the coculture supernatants was added to an equal volume of the Griess reagent in triplicate wells of a 96-well microplate (catalog no. 3075; Falcon, Lincoln Park, N.J.). After incubation at room temperature for 10 min, absorbance (540 nm) was determined in a Labsystems Multiskan MCC/340 microplate reader. NO2 was determined by using sodium nitrite as a standard (15).
Statistical analysis. Results are expressed as the mean ± standard deviation for at least three duplicate experiments (n = 6). Comparisons between groups were analyzed by the Student t test using the Pearson product moment correlation (program STATISTICA for Windows, version 4.0), with the significance level assumed to be P < 0.05. Additionally, the correlation between NO production and transformation of P. brasiliensis conidia (as log value) was calculated; NO production was considered the independent variable (the x axis), and the log of transformation was considered the dependent variable (the y axis).
| |
RESULTS |
|---|
|
|
|---|
Intracellular transformation of P. brasiliensis
conidia.
As shown in Fig. 2, in
nonactivated monolayers (no IFN-
), transformation of the conidia
began as early as 48 h of coculture and reached maximal values
(66% ± 8%) at 96 h. This period was chosen as the optimal time
for the next experiments.
|
Effect of rIFN-
activation of M
s on the transformation of
intracellular P. brasiliensis conidia.
Compared with
nonactivated M
s, the addition of rIFN-
resulted in significant
(P < 0.0001) dose-dependent inhibition of the conidium-to-yeast transformation process (Fig.
3A). Maximal inhibition was observed in
monolayers activated with 50 U of this cytokine per ml. To determine
whether the inhibitory effect exerted by rIFN-
-activated M
s on
intracellular conidia was mediated directly by this cytokine, we
conducted experiments involving the addition of anti-IFN-
MAb.
Initially, we determined if the various concentrations of the MAb to be
used were nontoxic for the cocultures after 96 h of incubation.
Similar transformation values were observed in both MAb-treated and
controls with no MAb. When MAb was added to the cytokine-activated
monolayers, we observed a significant (P < 0.0001) increase in the conidium-to-yeast transformation (42%) in
comparison with the cytokine-activated monolayers without MAb (3%).
Values were similar to those of controls without rIFN-
but with MAb.
On the other hand, the addition of different concentrations (10 to 200 U/ml) of rIFN-
to conidia alone did not affect their transformation.
|
NO production by rIFN-
-activated M
s.
We examined NO
production by rIFN-
-activated M
s which had been infected with
P. brasiliensis conidia and cocultured for 96 h. As
shown in Fig. 3B, nonactivated M
s had only basal production of NO
and low NO2
levels. However, when M
s were
activated with rIFN-
, there was a significant (P < 0.0001) increase in NO production. The maximal NO2
levels observed corresponded to
monolayers activated with 50 U of IFN-
per ml with high values of
43 ± 13 µM. We also determined NO production in the
supernatants of M
s that had been activated with the cytokine in the
absence of P. brasiliensis conidia; they also showed a
significant increase in NO production (33 µM) in comparison with both
nonactivated and noninfected M
s (5 µM).
has been suggested to play a role in M
NO production,
we attempted to determine if the latter was inhibited by anti-IFN-
antibody (36). Anti-mouse IFN-
antibody was used at
different concentrations and added to the cultures simultaneously with
the cytokine (50 U/ml). The levels of NO2
in
the supernatants were assayed at 96 h. NO production was
significantly reduced in the cytokine-activated cultures that had been
treated with antibody (4 µM), in contrast to cocultures activated
with the cytokine but not treated with MAb (50 µM).
Fungicidal effect of rIFN-
-activated M
s against P. brasiliensis conidia.
Monolayers activated with rIFN-
exerted a significant dose-dependent fungicidal activity compared with
nonactivated M
s (Fig. 4). Monolayers
activated with different concentrations of rIFN-
showed a
significant fungicidal activity (P < 0.001). The
maximal fungicidal activity, 71% ± 8%, was observed with monolayers
activated with 200 U/ml (P < 0.001).
|
Correlation between NO production and transformation of P. brasiliensis conidia.
The amount of NO produced by M
s
showed an inverse but significant correlation with the percentage of
conidia that had transformed into yeast in the monolayer (r =
0.8975) (Fig. 5). Data from cocultures showed that when the NO2
levels
reached 20 to 70 µM, there was complete inhibition of transformation.
On the other hand, monolayers that produced lower NO2
concentrations allowed transformation to
take place (Fig. 5).
|
Effect on the intracellular transformation of P. brasiliensis conidia by the addition of NO inhibitors.
The
proportions of P. brasiliensis conidia that transformed
inside rIFN-
(50 U/ml)-activated monolayers after treatment with different concentrations of the NO inhibitors ARG, AG, and LNMMA were
determined. As shown in Fig. 6A, the
addition of ARG, AG, or LNMMA resulted in significant (P < 0.0005) reversion of the inhibition process exerted by the
cytokine compared to rIFN-
-activated untreated monolayers. Values
were similar to those observed with normal M
s.
|
Blockage of NO production by addition of ARG, AG, and LNMMA.
NO production by rIFN-
(50 U/ml)-activated M
s was significantly
inhibited when different concentrations of ARG, AG, and LNMMA were
added (Fig. 6B). This inhibition was dose dependent, with total
blockage being exerted by the maximal concentration of each of the
three inhibitors used. Values obtained were similar to those for
nonactivated M
s. A significant (P < 0.0001)
decrease in levels of NO production was recorded in comparison to
cytokine-activated, non-inhibitor-treated M
s.
| |
DISCUSSION |
|---|
|
|
|---|
This study demonstrates, for the first time, that IFN-
-induced
production of NO renders murine M
s capable of restricting the
intracellular growth of P. brasiliensis, indicating that
this is an important mechanism displayed by effector cells. Support for
this conclusion is provided by the following observations: (i)
cytokine-induced production of NO by M
s inhibited the
conidium-to-yeast transformation process; (ii) addition of anti-IFN-
MAb reverted this inhibitory effect and resulted in blockade of NO
production; (iii) rIFN-
-activated M
s exerted an important
fungicidal activity against P. brasiliensis, as shown by a
significant CFU reduction in comparison with control, nonactivated
M
s; (iv) there was a significant inverse correlation between
NO2
levels and fungal transformation; and (v)
treatment with any of three different NO inhibitors blocked NO
synthesis and reverted the inhibition of the conidium-to-yeast transformation.
The results presented here confirm the protective role of IFN-
in
PCM, as previously demonstrated by several groups (5, 10,
33). Thus, this cytokine appears to be a major mediator of
resistance against P. brasiliensis infection in mice, as it promotes the antifungal activity of the M
s through NO production.
In human and experimental PCM, several findings suggest that
T-cell-activated M
s play a fundamental role in host resistance to
P. brasiliensis. When the fungus enters the host, it has to interact with various effector cells (M
s, polymorphonuclear
leukocytes, monocytes), and for successful colonization, it should
resist their microbiostatic and microbicidal mechanisms. Several groups have studied the interactions of murine and human effector cells, with
both the infective conidia and the parasitic yeast forms of P. brasiliensis (5). Treatment with lymphokine-containing supernatants from mitogen (concanavalin A)-stimulated spleen cells (8) or rIFN-
(5)-activated murine peritoneal
M
s resulted in potent fungicidal activity against P. brasiliensis. Furthermore, treatment of human monocytes with
cytokines, derived from supernatant of ConA-stimulated mononuclear
cells and cocultured with the fungus, significantly inhibited
multiplication compared to control monocytes (33). However,
killing by activated murine M
s could not be abrogated by superoxide
dismutase, catalase, or azide, suggesting that the fungicidal mechanism
was independent of the oxidative burst products (5). Our
results reveal that in vitro the inhibitory and/or killing mechanism
used by activated murine M
s against this pathogen involves NO
production, confirming the results obtained in vivo by Bocca et al.
(2) suggesting that NO is important in killing. However,
during the course of the infection with P. brasiliensis, NO
also induces immunosuppression, manifested by a decrease in Ia antigen
expression and a depression of the immunoproliferative responses of
spleen cells (2, 3). These NO-induced immunosuppressive effects have been reported previously; it has been shown that NO
production influences activated mouse M
by restricting T-cell expansion (30).
It is important to determine if in vivo NO plays a protective role in
PCM. Experiments are under way to confirm the expression of iNOS,
production of cytokines related to IFN-
or TNF-
, and the effect
of treatment with AG on the survival time of BALB/c mice infected
intranasally with P. brasiliensis conidia.
The inhibition of P. brasiliensis growth by NO and RNI, as
demonstrated in the present study, is in agreement with results obtained for most of the pathogenic fungi that have been studied (reviewed in reference 11). The anti-H.
capsulatum activity of rIFN-
-activated macrophage of the RAW
264.7 cell line depends on the generation of NO from
L-arginine and is completely inhibited by the NO inhibitor
LNMMA (27, 35). On the other hand, the inhibition of
C. neoformans growth by human cytokine-activated astrocytes
was paralleled by production of nitrite and reversed by the inhibitors
of the NO synthase, NG-methylmonoarginine and
NG-nitroarginine methyl ester (28).
Additionally, it has been demonstrated that interleukin-12 and
interleukin-18 synergistically induced NO-dependent anticryptococcal
activity of peritoneal cells by stimulating NK cells to produce IFN-
(45). Blasi et al. (1) demonstrated that hyphae
of Candida albicans, but not yeast cells, were susceptible
to the mechanisms employed by murine M
s, which likely involve stable
nitrogen-containing compounds. In addition, Vázquez-Torres et al.
(43) suggested that NO is candidastatic by itself and is
associated (but not involved directly) with other M
s candidacidal
agents, such as peroxynitrite (44).
Other fungi such as P. marneffei (13, 26) and
Rhizopus spp. (24) are also susceptible to the
effect of nitrogen compounds. Cogliati et al. (13), working
with a cell-free system and in a novel M
culture system,
demonstrated that in the presence of NO donors or inhibitors, the
L-arginine-dependent NO pathway plays an important role in
the murine M
immune response against P. marneffei
(13).
On the other hand, NO does not appear to be involved in the fungicidal
activity of either murine or human alveolar M
s against other fungi
such as A. fumigatus conidia (32, 41) and
P. carinii (40).
In our model, the results revealed that when peritoneal BALB/c mice
M
s were used, rIFN-
was able to induce fungicidal activity against P. brasiliensis conidia. Additionally, the
inhibition of NO synthesis provoked by the addition of LNMMA, ARG, or
AG was accompanied by reversion of the inhibition of fungal
transformation. It is suggested that this phenomenon is mediated by
production of nitric oxide and is dependent on the
L-arginine:NO pathway. Whether lack of conidium-to-yeast
transformation observed in vitro reflects the intracellular death of
the infective propagules remains to be confirmed. Further studies are
required to correlate death with the inability of the conidia to
convert to the tissue yeast cell form.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología, Francisco José de Caldas, COLCIENCIAS, Santafe de Bogotá-Colombia grant 2213-04-194-95, and the Corporación para Investigaciones Biológicas (CIB), Medellín, Colombia. We especially thank the COLCIENCIAS Young Research Program, which enabled training of A. González in the CIB laboratories.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas (CIB), Carrera 72 A No 78 B 141, A. A. 73 78, Medellín, Colombia. Phone: 57-4-441 08 55. Fax: 57-4-441 55 14. E-mail: lula{at}epm.net.co.
Editor: T. R. Kozel
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Blasi, E., I. Pitzurra, M. Puliti, A. R. Chimienti, R. Mazzolla, R. Barluzzi, and F. Bistoni. 1995. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect. Immun. 63:1806-1809[Abstract]. |
| 2. |
Bocca, A. L.,
E. E. Hayashi,
A. G. Pinheiro,
A. B. Furianetto,
A. P. Campanelli,
F. Q. Cunha, and F. Figueiredo.
1998.
Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response.
J. Immunol.
161:3056-3063 |
| 3. | Bocca, A. L., M. F. Silva, C. L. Silva, F. Q. Cunha, and F. Figueiredo. 1999. Macrophage expression of class II major histocompatibility complex gene products in Paracoccidioides brasiliensis-infected mice. Am. J. Trop. Med. Hyg. 61:280-287[Abstract]. |
| 4. |
Bogdan, C.,
S. Stenger,
M. Rollinghof, and W. Solbach.
1991.
Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin-4 synergizes with interferon- to activate murine macrophages for killing of Leishmania major amastigotes.
Eur. J. Immunol.
21:327-333[Medline].
|
| 5. |
Brummer, E.
1994.
Interaction of Paracoccidioides brasiliensis with host defense cells, p. 213-223.
In
M. Franco, C. Silva Lacaz, A. Restrepo Moreno, and G. del Negro (ed.), Paracoccidioidomycosis 1994. CRC Press, Boca Raton, Fla.
|
| 6. | Calich, V. L. G., A. Purchio, and C. R. Paula. 1978. A new fluorescent viability test for fungi cells. Mycopathologia 66:175-177. |
| 7. | Calich, V. L. G., T. L. Kipnis, M. Mariano, C. Fava Neto, and W. D. Dias. 1979. The activation of the complement system by Paracoccidioides brasiliensis "in vitro": its opsonic effect and possible significance for an in vivo model of infection. Clin. Immunol. Immunopathol. 12:20-30[CrossRef]. |
| 8. |
Cano, L. E.,
E. Brummer,
D. Stevens, and A. Restrepo.
1992.
Fate of conidia from Paracoccidioides brasiliensis after ingestion by resident macrophages or cytokine-treated macrophages.
Infect. Immun.
60:2096-2100 |
| 9. |
Cano, L. E.,
B. Gómez,
E. Brummer,
A. Restrepo, and D. A. Stevens.
1994.
Inhibitory effect of deferoxamine or macrophage activation on transformation of Paracoccidioides brasiliensis conidia ingested by macrophages: reversal by holotransferrin.
Infect. Immun.
62:1494-1496 |
| 10. |
Cano, L. E.,
S. S. Kashino,
C. Arruda,
D. André,
C. F. Xidieh,
L. M. Singer-Vermes,
C. A. C. Vaz,
E. Burger, and V. L. G. Calich.
1998.
Protective role of gamma interferon in experimental pulmonary paracoccidioidomycosis.
Infect. Immun.
66:800-806 |
| 11. | Cano, L. E., and A. González. 1998. Papel del óxido nítrico en las micosis. Médicas UIS 12:299-306. |
| 12. | Clark, J. A., K. A. Rockett, and W. B. Couden. 1992. Possible central role of nitric oxide in conditions similar to cerebral malaria. Lancet 340:894-896[CrossRef][Medline]. |
| 13. | Cogliati, M., A. Roverselli, J. R. Boelaert, D. Taramelli, L. Lombardi, and M. A. Viviani. 1997. Development of an in vitro macrophage system to assess Penicillium marneffei: growth and susceptibility to nitric oxide. Infect. Immun. 65:279-284[Abstract]. |
| 14. | Corbett, J. A., and M. L. McDaniel. 1996. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol. 268:398-408[Medline]. |
| 15. | Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407-2412[Abstract]. |
| 16. |
Drapier, J. C.,
J. Wietzerbin, and J. B. Hibbs, Jr.
1988.
Interferon- and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
Eur. J. Immunol.
18:1587-1592[Medline].
|
| 17. | Franco, M. 1987. Host parasite relationship in paracoccidioidomycosis. J. Med. Vet. Mycol. 25:5-18[Medline]. |
| 18. | Granger, D. L., J. B. Hibbs, Jr., J. R. Perfect, and D. T. Durack. 1990. Metabolic fate of L-arginine in relation to microbiostatic capability of macrophages. J. Clin. Investig. 85:264-273. |
| 19. | Green, S. J., and C. A. Nacy. 1993. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis. 6:383-396. |
| 20. | Griffith, O. W., and R. G. Kilbourn. 1996. Nitric oxide synthase inhibitors: amino acids. Methods Enzymol. 268:375-392[Medline]. |
| 21. | Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94[CrossRef][Medline]. |
| 22. | Hibbs, J. B., Jr., Z. Vavrin, and R. R. Taintor. 1987. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550-565[Abstract]. |
| 23. | James, S. L., and J. Glaven. 1989. Macrophage citotoxicity against schistosomula of Schistosoma mansoni involved arginine-dependent production of rective nitrogen intermediates. J. Immunol. 143:4208-4212[Abstract]. |
| 24. | Jorens, P. G., J. R. Boelaert, V. Halloy, R. Zamora, Y. J. Schneider, and A. G. Herman. 1995. Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect. Immun. 63:4489-4494[Abstract]. |
| 25. | Kashino, S. S., R. A. Fazioli, M. Moscardi-Bacchi, M. Franco, L. M. Singer-Vermes, E. Burger, and V. L. G. Calich. 1995. Effect of macrophage blockade on the resistance of inbred mice to Paracoccidioides brasiliensis infection. Mycopathologia 130:131-140[CrossRef][Medline]. |
| 26. | Kudeken, N., K. Kawakami, and A. Saito. 1998. Different susceptibilities of yeast and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophage. Clin. Exp. Immunol. 112:287-293[CrossRef][Medline]. |
| 27. |
Lane, T. E.,
G. C. Otero,
B. Wa-Hsieh, and D. H. Howard.
1994.
Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity.
Infect. Immun.
62:1940-1945 |
| 28. |
Lee, S. C.,
D. W. Dickson,
C. F. Brosnan, and A. Casadevall.
1994.
Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism.
J. Exp. Med.
180:365-369 |
| 29. | Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophage killing of Leishmania parasite "in vivo" is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794-4797[Abstract]. |
| 30. | MacMicking, J., Q. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350[CrossRef][Medline]. |
| 31. | Mauël, J., A. Ransijn, and Y. Buchmüller-Rouiller. 1991. Killing of Leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivates. J. Leukoc. Biol. 49:73-82[Abstract]. |
| 32. | Michaliszyn, E., S. Sènèchal, P. Martel, and L. Repentigny. 1995. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect. Immun. 63:2075-2078[Abstract]. |
| 33. | Moscardi-Bacchi, M., E. Brummer, and D. A. Stevens. 1994. Support of Paracoccidioides brasiliensis multiplication by human monocytes or macrophages: inhibition by activated phagocytes. J. Med. Microbiol. 40:159-164[Abstract]. |
| 34. |
Muñoz-Fernandez, M. A.,
M. A. Fernandez, and M. Fresno.
1992.
Synergism between tumor necrosis factor- and interferon- on macrophage activation for the killing of Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Eur. J. Immunol.
22:301-307[Medline].
|
| 35. |
Nakamura, L. T.,
B. A. Wo-Hsieh, and D. H. Howard.
1994.
Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum.
Infect. Immun.
62:680-684 |
| 36. | Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Investig. 79:319-326. |
| 37. | Norris, K. A., J. E. Schirimpf, J. L. Flynn, and S. M. Morris, Jr. 1995. Enhancement of macrophages microbicidal activity: supplemental arginine and citrulline augment nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi. Infect. Immun. 63:2793-2796[Abstract]. |
| 38. | Restrepo, A., M. E. Salazar, L. E. Cano, and M. M. Patiño. 1986. A technique to collect and dislodge conidia produced by Paracoccidioides brasiliensis mycelial form. J. Med. Vet. Mycol. 24:247-250[Medline]. |
| 39. | San Blas, G. 1993. Paracoccidioidomycosis and its etiologic agent Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 31:99-113[Medline]. |
| 40. | Shellito, J. E., J. K. Kolls, R. Olariu, and J. M. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173:432-439[Medline]. |
| 41. | Taramelli, D., M. G. Malabarba, G. Sala, N. Basilico, and G. Coccuzza. 1996. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J. Med. Vet. Mycol. 34:49-56[Medline]. |
| 42. |
Taylor-Robinson, A. W.,
R. S. Phillips,
A. Severn,
S. Moncada, and F. Y. Liew.
1993.
The role of TH1 and TH2 cells in a rodent malaria infection.
Science
260:1931-1934 |
| 43. | Vázquez-Torres, A., J. Jones-Carson, and E. Balish. 1995. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63:1142-1144[Abstract]. |
| 44. | Vázquez-Torres, A., J. Jones-Carson, and E. Balish. 1996. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. 64:3127-3133[Abstract]. |
| 45. | Zhang, T., K. Kawakami, M. H. Oureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin 12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65:3594-3599[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|